bioERGOtech is a foundation advancing Engineered Living Systems — transforming living cells into precisely controllable therapeutic agents through the convergence of synthetic biology, AI, and automated biomanufacturing.
bioERGOtech is a foundation dedicated to bridging the critical gap between biotech's promises and tangible medical breakthroughs. We develop pioneering research projects that advance Engineered Living Systems — turning cells into predictable, manufacturable, and controllable living medicines.
At its core, bioERGOtech transforms how biological research is conducted by developing "digital scientists" — AI-powered systems that make experiments smarter, not just faster, across our four integrated scientific pillars.
The foundation initiates and nurtures new research projects spanning digital twin therapeutics, synthetic biology and cell engineering, automated biomanufacturing, and integrated multi-omics analytics — all focused on translating scientific potential into real patient impact.
We believe in a pragmatic, focused approach that delivers real impact for patients suffering from chronic diseases.
Our approach combines cutting-edge AI technology with traditional scientific methods to create a more efficient research ecosystem. By implementing intelligent automation and optimization algorithms, we make every experiment count.
Instead of randomly exploring possibilities, our systems analyze data in real-time to determine the most promising pathways for further investigation, drastically reducing the time and resources needed to achieve meaningful results.
We focus on building solutions that address specific research markets. As the cost of building solutions has decreased dramatically, it's now possible to fulfill small niches efficiently and effectively.
We prioritize projects with speedy iteration times of less than a year from idea to implementation. This rapid development cycle allows us to quickly address emerging research needs.
Unlike moonshots that aim for distant breakthroughs, our "Earthshot" approach targets immediate human needs with practical solutions. We focus on understanding day-to-day challenges and developing innovations that make a tangible difference for patients today.
We identify core challenges in laboratory research for chronic diseases and develop targeted solutions that address fundamental issues rather than symptoms.
We create sophisticated algorithms that optimize experiments and research processes for maximum efficiency and breakthrough potential in chronic disease research.
We enable other research organizations to adopt and integrate our systems, transforming how chronic disease research is conducted worldwide.
Our foundation is guided by principles that foster meaningful collaboration and sustainable advancement across the global research landscape.
Our strategy centres on building dedicated, interdisciplinary teams that collaborate closely with partners worldwide to address pressing research challenges. By nurturing focused expertise alongside broad connectivity, we aim to complement and strengthen existing research ecosystems.
Through the development of foundational technologies applicable across therapeutic domains, we aspire to create an environment where progress in one scientific area naturally enriches neighbouring fields — fostering shared learning and collective impact.
We embrace emerging technologies and reimagine research processes from the ground up — seeking transformative advances rather than incremental improvements, while remaining open to learning from established methodologies.
When projects demonstrate viability, we support their growth into independent ventures with fair recognition for their creators — ensuring that those who build solutions are empowered to lead them forward.
We value lean, empowered teams supported by intelligent automation. This approach cultivates agility and creative problem-solving, allowing us to respond swiftly to evolving scientific and clinical needs.
We advance four integrated scientific pillars to transform living cells into precisely controllable therapeutic agents — predictable, manufacturable, and controllable living medicines.
Patient-specific computational models that predict therapeutic outcomes and enable real-time treatment optimization through mechanistic modelling, AI/ML-driven therapy selection, and predictive analytics.
Design and construction of programmable cellular systems with precise control over therapeutic function, safety, and persistence — including CRISPR editing, logic circuits, and next-generation receptor design.
Fully integrated robotic platforms that manufacture cell therapies with minimal human intervention — featuring closed-loop control systems, AI-driven process optimization, and real-time quality monitoring.
Comprehensive molecular profiling throughout manufacturing and treatment to predict product quality and patient response — spanning genomics, transcriptomics, proteomics, and metabolomics.
We engage with interconnected ecosystems where our scientific pillars can drive collaborative progress and shared value across diverse stakeholders.
Our work integrates across the full spectrum of the life sciences ecosystem — from academic institutions pursuing fundamental discovery to clinical centres translating insights into patient care, and from industry partners scaling therapeutic production to regulatory bodies shaping the path forward.
By building adaptable, open platforms, we aim to make advanced research capabilities accessible to a broad range of organisations, fostering a culture of shared knowledge and collective advancement.
Hospitals and clinical research centres working at the interface of discovery and patient care, seeking to integrate advanced therapies into practice.
Industry partners developing and manufacturing next-generation therapeutics, from drug discovery through to biomanufacturing at scale.
Universities and research institutions advancing fundamental science, training the next generation of researchers, and pioneering new methodologies.
Government bodies, regulatory agencies, and international organisations shaping policy frameworks for advanced therapies and innovation ecosystems.
We are building a network of innovation hubs across Europe and the Middle East to foster local expertise and global collaboration.
Our innovation hubs serve as focal points for collaboration between researchers, technologists, and healthcare professionals. Each hub brings unique regional strengths while contributing to a shared, interconnected research ecosystem.
From Taranto to Zurich to Riyadh, we are establishing specialised centres that address both local priorities and global scientific challenges — ensuring our work creates lasting value for communities and patients worldwide.
Our founding innovation hub in Southern Italy, where we are developing and testing our core technologies at the intersection of biotech and industrial heritage.
Our Swiss hub, embedded in one of Europe's leading life sciences and technology ecosystems, fostering collaboration with world-class academic and industry partners.
Our Middle Eastern hub, positioned to contribute to the region's growing commitment to healthcare innovation, biotechnology research, and knowledge-based economic development.
A Conversation with Guido Putignano on Navigating Academia and Entrepreneurship.
Know More →
The Bridge Between Research and Real-World Impact.
Know More →
A recap of our successful launch event for the Taranto Biotech Hub.
Know More →
How a young scientist is exploring connections between traditional medicine and modern technology in cancer treatment
Know More →
Meeting at the Minister of Public Education (Italy)
Know More →
Innovation in the sector
Know More →
Success Stories from the event
Know More →
Bioshot is a startup competition
Know More →
Video describing Taranto Biotech Days and the mission
Know More →